DaVita
DVA
#1400
Rank
$12.44 B
Marketcap
$141.86
Share price
1.36%
Change (1 day)
38.94%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

P/E ratio for DaVita (DVA)

P/E ratio as of July 2024 (TTM): 27.5

According to DaVita's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.4922. At the end of 2022 the company had a P/E ratio of 12.5.

P/E ratio history for DaVita from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202212.51.86%
202112.3-32.76%
202018.230.72%
201913.9-77.24%
201861.3197.62%
201720.639.47%
201614.8-73.11%
201554.9147.85%
201422.15.37%
201321.05.73%
201219.932.95%
201115.0-14.14%
201017.421.27%
200914.43.43%
200813.9-10.8%
200715.6-23.65%
200620.4-8.21%
200522.226.98%
200417.517.06%
200314.927.8%
200211.7-27.78%
200116.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
30.3 10.14%๐Ÿ‡บ๐Ÿ‡ธ USA
6.81-75.23%๐Ÿ‡บ๐Ÿ‡ธ USA
19.3-29.94%๐Ÿ‡บ๐Ÿ‡ธ USA
27.5 0.17%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.